Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
23.54
+0.57 (2.48%)
At close: Mar 10, 2026
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.59 billion as of March 10, 2026. Its market cap has decreased by -8.90% in one year.
Market Cap
2.59B
Enterprise Value
2.02B
Revenue
193.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.54
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.59B, a decrease of -36.32%. That is a compound annual growth rate of -12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 2.59B | -1.22% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang East Asia Pharmaceutical | 2.58B |
| Shanghai Serum Bio-Technology | 2.63B |
| Guiyang Xintian Pharmaceutical | 2.45B |
| Hubei Goto Biopharm | 2.39B |
| Jiangsu Gdk Biological Technology | 2.36B |
| Shandong Sito Bio-technology | 2.77B |
| Jilin Jian Yisheng Pharmaceutical | 2.78B |
| Shanghai Universal Biotech | 2.82B |